Actavis, Warner Chilcott In Merger Talks

Law360, New York (May 10, 2013, 9:36 PM EDT) -- Actavis Inc. and Warner Chilcott PLC confirmed Friday that they are in talks about a possible merger, one that would create a trans-Atlantic generic drug maker with $20 billion in combined market value and a trove of valuable drugs.

Both stressed that the negotiations were in early stages and declined to comment further.

If a deal materializes, it would create a trans-Atlantic drugmaker with a combined revenues of $8.5 billion and strong positions in different segments of the market. Actavis is the third-biggest U.S. maker of...
To view the full article, register now.